Fortin, PR, Lew, RA, Liang, MH, et al. (1995) Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol
Proudman, SM, Cleland, LG & James, MJ (2008) Dietary omega-3 fats for treatment of inflammatory joint disease: efficacy and utility. Rheum Dis Clin North Am
James, MJ, Proudman, SM & Cleland, LG (2010) Fish oil and rheumatoid arthritis: past, present and future. Proc Nutr Soc
Proudman, SM, James, MJ, Spargo, LD, et al. (2015) Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Ann Rheum Dis
Calder, PC (2013) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Br J Clin Pharmacol
Serhan, CN, Chiang, N & Van Dyke, TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol
James, MJ, Gibson, RA & Cleland, LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr
71, Suppl., 343S–348S.
Lawrence, T & Gilroy, DW (2007) Chronic inflammation: a failure of resolution?
Int J Exp Pathol
James, MJ, Sullivan, TR, Metcalf, RG, et al. (2014) Pitfalls in the use of randomised controlled trials for fish oil studies with cardiac patients. Br J Nutr
Zuijdgeest-van Leeuwen, SD, Dagnelie, PC, Rietveld, T, et al. (1999) Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. Br J Nutr
Metcalf, RG, James, MJ, Gibson, RA, et al. (2007) Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr
Brown, AJ, Pang, E & Roberts, DC (1991) Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr
Cao, J, Schwichtenberg, KA, Hanson, NQ, et al. (2006) Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem
Proudman, SM, Keen, HI, Stamp, LK, et al. (2007) Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Semin Arthritis Rheum
Fransen, J & van Riel, PL (2005) The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol
23, Suppl. 39, S93–S99.
Makinen, H, Kautiainen, H, Hannonen, P, et al. (2005) Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
Ann Rheum Dis
Pinals, RS, Masi, AT & Larsen, RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum
Metcalf, RG, Mantzioris, E, Cleland, LG, et al. (2003) A practical approach to increasing intake of n-3 fats: use of novel foods enriched with n-3 fats. Eur J Clin Nutr
Cleland, LG, James, MJ & Proudman, SM (2006) Fish oil: what the prescriber needs to know. Arthritis Res Ther
Barden, A, Mas, E, Croft, KD, et al. (2014) Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation. J Lipid Res
Mas, E, Croft, KD, Zahra, P, et al. (2012) Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem
Browning, LM, Walker, CG, Mander, AP, et al. (2012) Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr
Harris, WS & Von Schacky, C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease?